Is green hydrogen still Australia's next great opportunity? Here is what ASX investors need to know

Green hydrogen had a brutal 2025.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Green hydrogen has been one of the most hyped investment themes of the past five years.

Australia, with its vast renewable energy resources and proximity to energy-hungry Asian markets, has positioned itself as a potential global leader in green hydrogen exports.

But after a difficult 2025, which saw dozens of major projects cancelled or delayed globally and production costs stubbornly high, ASX investors may be asking whether now is the right time to capture this theme.

Hydrogen symbol with a globe.

Image source: Getty Images

Why the near-term picture is challenging

Green hydrogen has had a rough time of late.

The product currently costs significantly more to produce than fossil fuel alternatives.

Until the cost of renewable electricity falls further and electrolyser technology scales, green hydrogen will struggle to compete on price in most markets.

Investors who bought into the hype in 2021 and 2022 have learned this the hard way.

But the long-term case remains intact

Yet despite the doom and gloom, there is reason to be optimistic.

The global green hydrogen market was valued at US$9.09 billion in 2024 and is projected to reach US$134.86 billion by 2030, growing at a compound annual growth rate of 56.75%.

Australia has signed export agreements with Japan, South Korea, and Germany.

These markets all face structural energy insecurity and are actively seeking clean hydrogen imports.

Furthermore, Australia's National Hydrogen Strategy, backed by funding from the Australian Renewable Energy Agency, continues to invest in bringing production costs down through scale.

The question for investors may not therefore be whether green hydrogen has a future, but which ASX stocks offer the best exposure.

Fortescue

Fortescue Ltd (ASX: FMG) offers the most direct large-cap ASX exposure to green hydrogen through its Fortescue Energy division.

This division is pursuing a series of large-scale green hydrogen and green ammonia projects across multiple continents.

The company has committed to achieving net zero Scope 1 and 2 emissions across all its operations by 2030.

This target requires it to produce and consume significant volumes of green hydrogen itself.

The company's balance sheet, backed by its iron ore earnings, gives it the financial capacity to stay in the game longer than any pure-play hydrogen developer.

For investors, Fortescue offers a way to gain green hydrogen optionality while being underwritten by a profitable, cash-generative iron ore business.

Woodside

Woodside Energy Group Ltd (ASX: WDS) takes a more pragmatic approach to the hydrogen opportunity.

The company pursues both blue hydrogen projects using carbon capture and storage as a near-term bridge, and green hydrogen development as a longer-term ambition.

Its H2Perth project aims to produce green hydrogen and ammonia for export from Western Australia, leveraging the state's abundant solar and wind resources.

Woodside's financial strength, with operating revenue of US$3.26 billion in Q1 2026, gives it the capacity to fund long-dated hydrogen development alongside its core LNG business without straining the balance sheet.

In that sense, Woodside represents a more conservative and diversified way to access the theme.

Global X Hydrogen ETF

For investors who want broader exposure to the global hydrogen value chain without picking individual companies, the Global X Hydrogen ETF (ASX: HGEN) is a great ASX-listed option.

The fund invests in companies globally across hydrogen production, fuel cell development, and hydrogen infrastructure, and has delivered remarkable gains in the past 12 months.

That recovery reflects growing investor optimism that the cost curve for green hydrogen is beginning to inflect downward, even if commercial viability at scale remains a few years away.

Foolish Takeaway

For patient investors, Australia's advantages in renewable energy production make it one of the most credible potential green hydrogen exporters.

FMG and WDS offer diversified exposure with strong balance sheets as a backstop.

HGEN, on the other hand, provides a higher-risk, higher-reward way to invest in the entire global hydrogen value chain.

Motley Fool contributor Mark Verhoeven has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

A male ASX 200 broker wearing a blue shirt and black tie holds one hand to his chin with the other arm crossed across his body as he watches stock prices on a digital screen while deep in thought
Share Market News

5 things to watch on the ASX 200 on Wednesday

Here's what to expect on hump day on the benchmark index.

Read more »

Five young people sit in a row having fun and interacting with their mobile phones.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a disappointing return to trading for ASX investors today.

Read more »

Boys making faces and flexing.
Small Cap Shares

3 ASX small-cap shares to buy: Morgans

ASX small caps are underperforming in 2026, but Morgans sees opportunity with these 3 companies.

Read more »

A young man wearing a black and white striped t-shirt looks surprised.
Broker Notes

Three ASX shares to buy right now according to Morgans

One of these shares is tipped to more than double.

Read more »

A man in a business suit scratches his head looking at a graph that started high then dips, then starts to go up again like a rollercoaster.
Broker Notes

Down 28% in a year, should I buy the dip on Resmed shares right now?

A leading analyst provides his outlook for the beaten-down ResMed share price.

Read more »

Business man marking buy on board and underlining it.
Broker Notes

Leading brokers name 3 ASX shares to buy today

Brokers believe that now could be the time to buy these shares.

Read more »

A businessman points to an arrow going up on a graph, indicating a share price rise for an ASX company.
Broker Notes

Up 1,277% in a year, why 4DMedical shares are tipped for more outsized gains

A leading analyst forecasts more outperformance from 4DMedical’s rocketing shares. But why?

Read more »

Frustrated stock trader screaming while looking at mobile phone, symbolising a falling share price.
Share Fallers

Why Aeris Resources, Northern Star, REA Group, and Weebit Nano shares are falling today

These shares are starting the week in the red. What's happening?

Read more »